-
2023-508960-31-00
5
2024-12-03
Metastatic HER2-positive breast cancer
-
2023-508400-38-00
4
2024-11-29
meningioma
-
2024-511313-38-00
4
2024-11-17
Soft Tissue Sarcoma
-
2023-504620-26-00
4
2024-11-04
Triple negative breast cancer
-
2024-515300-39-00
4
2024-10-18
METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA OF G
-
2024-511070-68-01
5
2024-09-24
Ampullary adenocarcinoma
-
2022-502408-57-00
5
2024-09-04
Novo metastatic hormone-sensitive prostate cancer (mHSPC) patients hav
-
2024-515297-27-00
5
2024-08-14
colon carcinoma
-
2024-515788-73-00
4
2024-07-30
MICROSATELLITE STABLE (MSS) METASTATIC COLORECTAL CANCER AND
A HIGH IM
-
2024-512872-36-00
5
2024-07-25
obstetric_pathological delivery
-
2024-514107-34-00
4
2024-07-18
BRAF V600E-MUTATED LOCALISED COLON OR UPPER RECTUM CANCER
-
2023-509761-21-00
5
2024-07-08
Metastatic colorectal cancer
-
2023-507914-28-00
10
2024-06-19
Platinum-resistant, high-grade serous ovarian cancer (OVC),high-grade
-
2023-506705-20-00
4
2024-06-14
relapsed or refractory patients with aggressive large B-cell lymphoma
-
2023-504251-27-00
7
2024-05-27
Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mut
-
2023-507871-23-00
5
2024-05-27
Relapsed/Refractory Multiple Myeloma
-
2024-516456-17-00
5
2024-05-07
patients admitted for an obstructive colon cancer
-
2023-506753-38-00
4
2024-04-16
metastatic gastric adenocarcinoma
-
2022-502984-39-00
5
2023-12-13
Severe Uncontrolled Asthma
Asthma (an illness that causes breathing di
-
2023-510541-25-00
1
2023-10-09
Relapsed/Refractory B-cell Malignancies
-
2022-500974-33-00
5
2023-08-12
acute venous thromboembolism event
-
2022-502229-16-00
5
2023-06-19
Ventilator acquired pneumonia
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2024-514636-25-00
4
2023-05-04
Stage IIa/IIb < 3 cm seminoma